LOI of IGF2 is a frequent epigenetic change in CRC [28,67,68]: 63% CRC samples were found to have an LOI in tumors, while ~22% had an LOI in the normal control group [69]. This evidence concerns the gene IGF2 and colorectal carcinoma.